Cite
Merritt K, McGuire PK, Egerton A. Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data. JAMA Psychiatry. 2021;78(6):667-681doi: 10.1001/jamapsychiatry.2021.0380.
Merritt, K., McGuire, P. K., Egerton, A., Aleman, A., Block, W., Bloemen, O. J. N., Borgan, F., Bustillo, J. R., Capizzano, A. A., Coughlin, J. M., De la Fuente-Sandoval, C., Demjaha, A., Dempster, K., Do, K. Q., Du, F., Falkai, P., Galinska-Skok, B., Gallinat, J., Gasparovic, C., Ginestet, C. E., Goto, N., Graff-Guerrero, A., Ho, B. C., Howes, O. D., Jauhar, S., Jeon, P., Kato, T., Kaufmann, C. A., Kegeles, L. S., Keshavan, M., Kim, S. Y., Kunugi, H., Lauriello, J., Liemburg, E. J., Mcilwain, M. E., Modinos, G., Mouchlianitis, E. D., Nakamura, J., Nenadic, I., Öngür, D., Ota, M., Palaniyappan, L., Pantelis, C., Plitman, E., Posporelis, S., Purdon, S. E., Reichenbach, J. R., Renshaw, P. F., Russell, B. R., Sawa, A., Schaefer, M., Shungu, D. C., Smesny, S., Stanley, J. A., Stone, J. M., Szulc, A., Taylor, R., Thakkar, K., Théberge, J., Tibbo, P. G., van Amelsvoort, T., Walecki, J., Williamson, P. C., Wood, S. J., Xin, L., & Yamasue, H. (2021). Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data. JAMA psychiatry, 78(6), 667-681. https://doi.org/10.1001/jamapsychiatry.2021.0380
Merritt, Kate, et al. "Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data." JAMA psychiatry vol. 78,6 (2021): 667-681. doi: https://doi.org/10.1001/jamapsychiatry.2021.0380
Merritt K, McGuire PK, Egerton A, Aleman A, Block W, Bloemen OJN, Borgan F, Bustillo JR, Capizzano AA, Coughlin JM, De la Fuente-Sandoval C, Demjaha A, Dempster K, Do KQ, Du F, Falkai P, Galinska-Skok B, Gallinat J, Gasparovic C, Ginestet CE, Goto N, Graff-Guerrero A, Ho BC, Howes OD, Jauhar S, Jeon P, Kato T, Kaufmann CA, Kegeles LS, Keshavan M, Kim SY, Kunugi H, Lauriello J, Liemburg EJ, Mcilwain ME, Modinos G, Mouchlianitis ED, Nakamura J, Nenadic I, Öngür D, Ota M, Palaniyappan L, Pantelis C, Plitman E, Posporelis S, Purdon SE, Reichenbach JR, Renshaw PF, Russell BR, Sawa A, Schaefer M, Shungu DC, Smesny S, Stanley JA, Stone JM, Szulc A, Taylor R, Thakkar K, Théberge J, Tibbo PG, van Amelsvoort T, Walecki J, Williamson PC, Wood SJ, Xin L, Yamasue H. Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data. JAMA Psychiatry. 2021 Jun 01;78(6):667-681. doi: 10.1001/jamapsychiatry.2021.0380. PMID: 33881460; PMCID: PMC8060889.
Copy
Download .nbib